the aid library

LIST OPTIONS

Filter

511

Sort by:

Direction:

Download (829)

View PDF (1255)

Guidelines for the production, control and regulation of snake antivenom immunoglobulins

World Health Organization (WHO) (2017) C_WHO

Replacement of Annex 2 of WHO Technical Report Series, No. 964... more

Download (582)

View PDF (1294)

Asylbewerberkinder und ihre Familien in Kindertageseinrichtungen

Bayerisches Staatsminiserium für Arbeit und Soziales, Familie und Integration (2016) CC

Informationen für Kindertageseinrichtungen in Bayern

Download (757)

View PDF (1483)

Predictive values of Ebola RDTs and implications for decision-makers

World Health Organization (WHO) (2015) C_WHO

Annex to Selection and use of Ebola in vitro diagnostic assays

Download (46)

View PDF (57)

Poremećaji koji se javljaju kao posljedica traume i posttraumatski stresni poremećaj (PTSP)

Ethno-Medizinisches Zentrum e. V. (2015) C1

Ovaj vodič treba da pruži opšte/opće informacije o ovim oboljenjima, takozvanim „poremećajima koji se javljaju kao posljedica traume“ i naročito o „posttraumatskom stresnom poremećaju“ (PTSP). Osim toga, on treba da pomogne u traženju mogućnosti liječenja i savjetovanja.

Download (63)

View PDF (44)

Flyer Mpox

Robert Koch Institut (2024) CC

Flyer German

Download (45)

View PDF (42)

Trauma - co robić? Aby nie musieli się już Państwo czuć tak bezradni

Dreiner, M.; Weber, T. Unfallkasse Berlin (2022) CC

Informacje dla osób dotkniętych traumą i ich bliskich W trakcie naszej pracy wielokrotnie otrzymywaliśmy zapytania o krótkie pisemne informacje na temat tego, jak zachowywać się po traumatycznych doświadczeniach. Osoby dotknięte traumą życzyły sobie możliwości przeczytania rzetelnych... more

Download (54)

View PDF (48)

Jak pracovat s traumatem? Abyste se už nemuseli cítit tak bezmocní

Dreiner, M.; Weber, T. Unfallkasse Berlin (2022) CC

Informace pro silně traumatizované osoby a jejich blízké Při naší práci jsme byli opakovaně do tazováni, zda bychom mohli poskytnout stručné písemné informace o tom, jak se chovat po traumatických zážitcích. Trau matizované osoby si přály v klidu přečíst srozumitelné info... more

Download (111)

View PDF (125)

Step up the fight. Investment case: Zusammenfassung

The Global Fund Reliefweb OCHA (2019) CC

Wir haben die Chance, die Welt von diesen drei Krankheiten zu befreien – Krankheiten, die zum Tod von Millionen von Menschen und zur Auflösung von Gemeinschaften auf allen Kontinenten geführt haben. Wir haben die Chance, einen wichtigen Schritt nach vorn zu gehen – einen Schritt in Richtung ... more

Download (259)

View PDF (355)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (395)

View PDF (545)

Formulaire de rapport de cas pour les médecins. Admissions
recommended

Organisation Mondiale de la Santé OMS (2018) C_WHO

Ces formulaires sont destinés uniquement aux cliniciens et infirmiers s’occupant de patients atteints de la maladie à virus Ebola. Ils fournissent des informations standardisées qui doivent être collectées par les cliniciens au moment de l’admission, tous les jours, et lors de la sortie du ... more

Download (166)

View PDF (192)

WHO pharmaceuticals newsletter - No. 1, 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f... more

Download (111)

View PDF (291)

Human African Trypanosomiasis (HAT) - Sleeping Sickness

Drugs for Neglected Diseases initiative DNDi (2008) C2

At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified treatment which can be orally administered, impl... more

Download (148)

View PDF (177)

Ripoti ya unep ya kukabiliana na pengo la uzalishaji wa gesi chafu ya mwaka wa 2022, ujumbe muhimu unaowasilishwa

UN Enivronemnt Programme UNEP (2022) C1

As climate impacts intensify across the globe, nations must dramatically increase funding and implementation of actions designed to help vulnerable nations and communities adapt to the climate storm

Download (1425)

View PDF (2720)

Hatua za kwanza zinazotakiwa kuchukua kwenye mlipuko mkali wa magonjwa ya kuhara

World Health Organization (2010) C_WHO

This leaflet aims at guiding health workers though the very first days of an outbreak. It addresses the following questions: Is this the beginning of an outbreak? Is the patient suffering from cholera or shigella? The leaflet also has sections on how to protect the community, how to t... more

Download (171)

View PDF (133)

COVID-19 Treatment Guidelines

National Department of Health, South Africa (2022) CC

Updated Treatment Guidelines

Download (128)

View PDF (166)

Neurology and COVID-19: Scientific brief, 29 September 2021

World Health Organization WHO (2021) C_WHO

29 September 2021

Download (140)

View PDF (210)

Shujaa Wangu ni Wewe 2021 - Jinsi watoto wanavyoweza kuwa na matumaini wakati wa COVID-19!

Inter-Agency Standing Committee IASC; World Health Organization (WHO); UNICEF; et al. (2021) C_WHO

A new story book that aims to help children understand and come to terms with COVID-19 has been produced With the help of a fantasy creature, Ario, “My Hero is You, How kids can fight COVID-19!” explains how children can protect themselves, their families and friends from coronavirus and how to... more

Download (90)

View PDF (576)

Leksik “Sante pou tout moun”

Hesperian (2021) CC

Hesperian created a 4-language Glossary of Health Terms for health workers cooperating across language barriers. These resources will be of use during this crisis by both Haitian health workers and any foreign health workers working in solidarity with them.

Download (95)

View PDF (179)

Overview of Mtoto Mwerevu Stunting Reduction Toolkit, Swahili Version

IMA World Health (2021) CC

The Mtoto Mwerevu Stunting Reduction Toolkit is a resource for government and organisations involved in addressing stunting and broader nutrition issues in Tanzania. The toolkit was developed in conjunction with the Government of Tanzania (GoT) with funding from UK Aid as part of the Addressing Stun... more

Download (89)

View PDF (562)

Eine Ausnahmesituation für die gesamte Familie

Ethno-Medizinischen-Zentrum und der Beauftragten der Bundesregierung für Migration, Flüchtlinge und Integration (2021) CC

Eine Ausnahmesituation für die gesamte FamilieAnregungen zur Verhinderung von Gewalt in der Familie durch die Kontaktbeschränkungen während der Corona-Zeiten Die mit der Corona-Pandemie verbundenen Kontaktbeschränkungen stellen viele Familien weiterhin vor große Herausforderungen. Im Alltag ko... more

Formulaire de rapport de cas pour les médecins. Admissions recommended

Formulaire de rapport de cas pour les médecins. Admissions
recommended